IRA Creates Unintended Complications for Biologics

IRA Creates Unintended Complications for Biologics

Source: 
BioSpace
snippet: 

The main goal of the August 2022 legislation was to lower the prices of prescription drugs. But it ended up being much more complicated than that, and how its components are rolled out through 2026 will have ramifications across research and development.